U.S. Markets close in 2 hrs 34 mins

Merck & Co., Inc. (MRK)

NYSE - Nasdaq Real Time Price. Currency in USD
Add to watchlist
64.99-0.05 (-0.08%)
As of 1:25PM EDT. Market open.
People also watch
Interactive chart
Previous Close65.04
Bid0.00 x
Ask0.00 x
Day's Range64.92 - 65.20
52 Week Range55.10 - 66.80
Avg. Volume8,994,761
Market Cap177.76B
PE Ratio (TTM)41.42
Earnings DateN/A
Dividend & Yield1.88 (2.94%)
Ex-Dividend Date2017-03-13
1y Target EstN/A
Trade prices are not sourced from all markets
  • American City Business Journals1 hour ago

    ​Cambridge biotech Enumeral faces uncertain future as cash dries up

    Cambridge cancer drug developer Enumeral could be forced to downsize, file for bankruptcy or sell its assets unless it quickly raises additional capital, the company said this week. Amid the cash crunch, Enumeral said it is “exploring a range of potential transactions.” According to the company, that could include a public or private offering, debt financing, collaborations and licensing deals, or a potential merger or asset sale. A representative for Enumeral did not immediately respond to an interview request on Friday.

  • UnitedHealth's (UNH) Business Unit Collaborates with Merck
    Zacks3 hours ago

    UnitedHealth's (UNH) Business Unit Collaborates with Merck

    UnitedHealth Group, Inc.???s (UNH) information and technology-enabled health services business "Optum" recently announced its collaboration with Merck & Co. Inc (MRK).

  • Merck (MRK) Buys Rights to Anti-tau Antibody for Alzheimer
    Zacks4 hours ago

    Merck (MRK) Buys Rights to Anti-tau Antibody for Alzheimer

    Merck & CO, Inc. (MRK) announced that it has bought exclusive worldwide license from Teijin Pharma for the development, manufacture and commercialization of an investigational preclinical anti-tau antibody.